The latest health and social care news and a look at research and development into the treatment of common and rare diseases alike. We also look at the vital changes being made to help deliver effective healthcare through the digital transformation within the NHS.
Andrea Ammon, Director at the European Centre for Disease Prevention and Control, takes us on a journey from COVID-19 to the future of public health surveillance.
Dr Anas Nader, co-founder and CEO of Patchwork Health, discusses why we must find reliable ways to keep NHS teams safe when they can't work from home during the pandemic.
Chris Wakefield, Vice President of GOJO Industries-Europe Ltd, explores how businesses can navigate the increase in cleaning products on the market and select products that will best meet their needs.
When it comes to COVID-19 testing labs, size isn’t everything, according to Alan Thornhill, UK Country Manager at Igenomix and Honorary Professor of Reproductive Genetics at the University of Kent, who spoke to Natalie Broome (MSc student, Kent).
The European Centre for Disease Control (ECDC) and the World Health Organisation (WHO) found that HIV testing in Europe is not good enough - 53% of diagnosis happens when the immune system is already failing.
The Oxford and AstraZeneca vaccine trial gave an accidental half-dose to 3,000 people - but this mistake is the reason the vaccine acted as 90% efficient.
Dr Ganesan Baranidharan, consultant in anaesthesia and pain medicine at the Leeds Teaching Hospitals NHS Trust, explains the power of neuromodulation for managing chronic pain and explains why comprehensive evidence is needed.
Helen Dempster, Founder of Karantis360, explores the benefits of Spark DPS and what future developments are required to improve the public sector health procurement journey even further.
Today (20 November) Pfizer and BioNTech are sending their drug for approval to the FDA, meaning that the most vulnerable Americans could get the vaccine in December.
Asymptomatic older patients of COVID-19 are one of the most difficult to identify - now, researchers find that delirium could be an indicator of the virus
